Research Article
Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression
Figure 2
Hepatocyte fat accumulation after 12 weeks of pioglitazone treatment according to CAR activity. Representative hematoxylin and eosin staining of liver of mice. (a) CAR+/+ control. (b) CAR-/- control. (c) CAR+/+ TCPOBOP. (d) CAR+/+ with pioglitazone. (e) CAR-/- with pioglitazone. (f) CAR+/+ TCPOBOP with pioglitazone.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |